These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16507647)

  • 1. Application of biocatalysis to drug metabolism: preparation of mammalian metabolites of a biaryl-bis-sulfonamide AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor potentiator using Actinoplanes missouriensis.
    Zmijewski M; Gillespie TA; Jackson DA; Schmidt DF; Yi P; Kulanthaivel P
    Drug Metab Dispos; 2006 Jun; 34(6):925-31. PubMed ID: 16507647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and structure elucidation of urinary metabolites of mitoxantrone.
    Blanz J; Mewes K; Ehninger G; Proksch B; Greger B; Waidelich D; Zeller KP
    Cancer Res; 1991 Jul; 51(13):3427-33. PubMed ID: 2054783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA potentiator treatment of cognitive deficits in Alzheimer disease.
    Chappell AS; Gonzales C; Williams J; Witte MM; Mohs RC; Sperling R
    Neurology; 2007 Mar; 68(13):1008-12. PubMed ID: 17389305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.
    Espina R; Yu L; Wang J; Tong Z; Vashishtha S; Talaat R; Scatina J; Mutlib A
    Chem Res Toxicol; 2009 Feb; 22(2):299-310. PubMed ID: 18980340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, structural elucidation and biosynthesis of 3-hydroxy-6-dimethylallylindolin-2-one, a novel prenylated indole derivative from Actinoplanes missouriensis.
    Satou R; Izumikawa M; Katsuyama Y; Matsui M; Takagi M; Shin-ya K; Ohnishi Y
    J Antibiot (Tokyo); 2014 Mar; 67(3):231-6. PubMed ID: 24220111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
    Shaffer CL; Langer CS
    J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro metabolism of lefucoxib in rats.
    Bi X; Meng Z; Chen H; Zhu X; Dou G
    J Pharm Biomed Anal; 2008 Sep; 48(1):134-9. PubMed ID: 18538525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
    Colizza K; Awad M; Kamel A
    Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and structural elucidation of tiamulin metabolites formed in liver microsomes of pigs.
    Lykkeberg AK; Cornett C; Halling-Sørensen B; Hansen SH
    J Pharm Biomed Anal; 2006 Sep; 42(2):223-31. PubMed ID: 16725295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects.
    Jhee SS; Chappell AS; Zarotsky V; Moran SV; Rosenthal M; Kim E; Chalon S; Toublanc N; Brandt J; Coutant DE; Ereshefsky L
    J Clin Pharmacol; 2006 Apr; 46(4):424-32. PubMed ID: 16554450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite identification in drug discovery.
    Watt AP; Mortishire-Smith RJ; Gerhard U; Thomas SR
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):57-65. PubMed ID: 12613277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.
    Cannell RJ; Knaggs AR; Dawson MJ; Manchee GR; Eddershaw PJ; Waterhouse I; Sutherland DR; Bowers GD; Sidebottom PJ
    Drug Metab Dispos; 1995 Jul; 23(7):724-9. PubMed ID: 7587961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of gallic acid by Beauveria sulfurescens ATCC 7159.
    Hsu FL; Yang LM; Chang SF; Wang LH; Hsu CY; Liu PC; Lin SJ
    Appl Microbiol Biotechnol; 2007 Mar; 74(3):659-66. PubMed ID: 17111140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.
    Fancy SA; Beckonert O; Darbon G; Yabsley W; Walley R; Baker D; Perkins GL; Pullen FS; Rumpel K
    Rapid Commun Mass Spectrom; 2006; 20(15):2271-80. PubMed ID: 16810707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana.
    Ma B; Huang HH; Chen XY; Sun YM; Lin LH; Zhong DF
    Acta Pharmacol Sin; 2007 Jul; 28(7):1067-74. PubMed ID: 17588344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.